Self-assembled Nano-PROTACs: bridging chemical design and biological barriers in targeted protein degradation
Advanced Drug Delivery Reviews · 2026-07 · 234 · 115861
DOI: 10.1016/j.addr.2026.115861 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Ni-Yuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience an…. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Nanostructures, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 195 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Self-assembled Nano-PROTACs represent an emerging class of programmable supramolecular degraders that integrate targeted protein degradation with nanoscale delivery to overcome the intrinsic limitations of conventional PROTACs. Conventional PROTACs are often constrained by poor solubility, limited membrane permeability, suboptimal pharmacokinetics, and insufficient tissue selectivity, collectively hindering their clinical translation. Through rational engineering of polymer, peptide or aptamer conjugation, Nano-PROTACs autonomously organize into well-defined nanostructures that enhance systemic stability, circulation time, tumour accumulation, and intracellular bioavailability. These assemblies enable controlled cargo release, multivalent target engagement, and spatiotemporal precision in regulating protein degradation. In this review, we summarize the evolution of PROTAC technologies, key mechanistic and translation barriers, in addition to recent advances in Nano-PROTACs design. We further discuss therapeutic applications across oncology, immuno-modulation, neurodegenerative disorders, and metabolic diseases, highlight major challenges and future directions toward predictive design, scalable manufacturability, and clinical translation of next-generation Nano-PROTAC therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing, China; Center of Materials Science and…
- School of Materials Science and Engineering, Beijing Institute of Technology (BIT), Beijing, China. Electronic address: wangy@bit.edu.cn.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing, China. Electronic address: anhw@nanoctr…
Förderung
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, N. Y., Liang, J. X., Hu, B. N., Wang, Y., An, H. W., & Wang, H. (2026). Self-assembled Nano-PROTACs: bridging chemical design and biological barriers in targeted protein degradation. Advanced Drug Delivery Reviews, 234, 115861. https://doi.org/10.1016/j.addr.2026.115861
Vancouver
Zhang NY, Liang JX, Hu BN, Wang Y, An HW, Wang H. Self-assembled Nano-PROTACs: bridging chemical design and biological barriers in targeted protein degradation. Advanced Drug Delivery Reviews. 2026;234:115861. doi:10.1016/j.addr.2026.115861
BibTeX
@article{Zhang2026,
author = {Zhang, Ni-Yuan and Liang, Jian-Xiao and Hu, Bei-Ning and Wang, Yi and An, Hong-Wei and Wang, Hao},
title = {Self-assembled Nano-PROTACs: bridging chemical design and biological barriers in targeted protein degradation},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {234},
pages = {115861},
doi = {10.1016/j.addr.2026.115861}
}
EUVIMED